Myles Minter
Stock Analyst at William Blair
(4.98)
# 53
Out of 4,668 analysts
594
Total ratings
66.2%
Success rate
38.1%
Average return
Main Sectors:
Stocks Rated by Myles Minter
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| RAPP Rapport Therapeutics | Maintained: Buy | n/a | $49.07 | - | 3 | Aug 20, 2026 | |
| MRNA Moderna | Upgraded: Buy | n/a | $174.38 | - | 30 | Aug 19, 2026 | |
| IONS Ionis Pharmaceuticals | Maintained: Buy | n/a | $60.80 | - | 52 | Aug 14, 2026 | |
| VTGN Vistagen Therapeutics | Maintained: Hold | n/a | $0.2441 | - | 13 | Aug 14, 2026 | |
| NMRA Neumora Therapeutics | Reiterated: Buy | n/a | $1.64 | - | 16 | Aug 14, 2026 | |
| CAMP Camp4 Therapeutics | Reiterated: Buy | n/a | $4.65 | - | 12 | Aug 14, 2026 | |
| OVID Ovid Therapeutics | Maintained: Buy | n/a | $2.93 | - | 11 | Aug 13, 2026 | |
| ANRO Alto Neuroscience | Reiterated: Buy | n/a | $34.89 | - | 14 | Aug 13, 2026 | |
| IMUX Immunic | Reiterated: Buy | n/a | $16.45 | - | 14 | Aug 11, 2026 | |
| BBIO BridgeBio Pharma | Reiterated: Buy | n/a | $83.95 | - | 11 | Aug 11, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | n/a | $14.14 | - | 12 | Aug 11, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | n/a | $552.06 | - | 34 | Aug 10, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | n/a | $218.20 | - | 64 | Aug 10, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | n/a | $13.61 | - | 26 | Aug 10, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | n/a | $10.28 | - | 22 | Aug 7, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | n/a | $25.69 | - | 14 | Aug 7, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | n/a | $2.43 | - | 12 | Aug 7, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | n/a | $62.32 | - | 15 | Aug 6, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | n/a | $13.28 | - | 18 | Aug 6, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | n/a | $13.95 | - | 12 | Aug 6, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | n/a | $4.25 | - | 20 | Aug 5, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | n/a | $7.78 | - | 13 | Aug 5, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | n/a | $113.70 | - | 21 | Aug 4, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | n/a | $155.54 | - | 32 | Jul 31, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | n/a | $16.02 | - | 9 | Jul 31, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | n/a | $242.61 | - | 17 | Jul 30, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | n/a | $221.56 | - | 31 | Jul 29, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | n/a | $1,032.86 | - | 19 | Jun 24, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | n/a | $13.52 | - | 1 | Mar 31, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $4.08 | n/a | 3 | Dec 22, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | n/a | $3.93 | n/a | 3 | Sep 28, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | n/a | $386.19 | n/a | 5 | Mar 3, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $4.79 | n/a | 15 | Dec 29, 2022 |
Rapport Therapeutics
Aug 20, 2026
Maintained: Buy
Price Target: n/a
Current: $49.07
Upside: -
Moderna
Aug 19, 2026
Upgraded: Buy
Price Target: n/a
Current: $174.38
Upside: -
Ionis Pharmaceuticals
Aug 14, 2026
Maintained: Buy
Price Target: n/a
Current: $60.80
Upside: -
Vistagen Therapeutics
Aug 14, 2026
Maintained: Hold
Price Target: n/a
Current: $0.2441
Upside: -
Neumora Therapeutics
Aug 14, 2026
Reiterated: Buy
Price Target: n/a
Current: $1.64
Upside: -
Camp4 Therapeutics
Aug 14, 2026
Reiterated: Buy
Price Target: n/a
Current: $4.65
Upside: -
Ovid Therapeutics
Aug 13, 2026
Maintained: Buy
Price Target: n/a
Current: $2.93
Upside: -
Alto Neuroscience
Aug 13, 2026
Reiterated: Buy
Price Target: n/a
Current: $34.89
Upside: -
Immunic
Aug 11, 2026
Reiterated: Buy
Price Target: n/a
Current: $16.45
Upside: -
BridgeBio Pharma
Aug 11, 2026
Reiterated: Buy
Price Target: n/a
Current: $83.95
Upside: -
Aug 11, 2026
Reiterated: Hold
Price Target: n/a
Current: $14.14
Upside: -
Aug 10, 2026
Reiterated: Buy
Price Target: n/a
Current: $552.06
Upside: -
Aug 10, 2026
Maintained: Buy
Price Target: n/a
Current: $218.20
Upside: -
Aug 10, 2026
Reiterated: Buy
Price Target: n/a
Current: $13.61
Upside: -
Aug 7, 2026
Maintained: Buy
Price Target: n/a
Current: $10.28
Upside: -
Aug 7, 2026
Maintained: Buy
Price Target: n/a
Current: $25.69
Upside: -
Aug 7, 2026
Reiterated: Hold
Price Target: n/a
Current: $2.43
Upside: -
Aug 6, 2026
Maintained: Buy
Price Target: n/a
Current: $62.32
Upside: -
Aug 6, 2026
Reiterated: Buy
Price Target: n/a
Current: $13.28
Upside: -
Aug 6, 2026
Maintained: Buy
Price Target: n/a
Current: $13.95
Upside: -
Aug 5, 2026
Maintained: Buy
Price Target: n/a
Current: $4.25
Upside: -
Aug 5, 2026
Maintained: Buy
Price Target: n/a
Current: $7.78
Upside: -
Aug 4, 2026
Reiterated: Buy
Price Target: n/a
Current: $113.70
Upside: -
Jul 31, 2026
Reiterated: Buy
Price Target: n/a
Current: $155.54
Upside: -
Jul 31, 2026
Maintained: Buy
Price Target: n/a
Current: $16.02
Upside: -
Jul 30, 2026
Maintained: Buy
Price Target: n/a
Current: $242.61
Upside: -
Jul 29, 2026
Maintained: Buy
Price Target: n/a
Current: $221.56
Upside: -
Jun 24, 2026
Maintained: Buy
Price Target: n/a
Current: $1,032.86
Upside: -
Mar 31, 2026
Maintained: Buy
Price Target: n/a
Current: $13.52
Upside: -
Dec 22, 2023
Rated: Hold
Price Target: n/a
Current: $4.08
Upside: n/a
Sep 28, 2023
Maintained: Buy
Price Target: n/a
Current: $3.93
Upside: n/a
Mar 3, 2023
Downgraded: Hold
Price Target: n/a
Current: $386.19
Upside: n/a
Dec 29, 2022
Rated: Hold
Price Target: n/a
Current: $4.79
Upside: n/a